Goldman Sachs Knock-Out GEBN/ DE000GG1U8B4 /
05/06/2024 11:44:07 | Chg.-0.02 | Bid22:00:41 | Demandez à22:00:41 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
1.42EUR | -1.39% | - Bid taille: - |
- Ask la taille: - |
GEBERIT N | 411.2707 CHF | 31/12/2078 | Call |
GlobeNewswire
22:18
MBUU STOCKHOLDERS – Contact Robbins LLP for Information About Pending Leading Plaintiff Deadline in ...
GlobeNewswire
22:18
AKRO STOCKHOLDERS - Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in...
GlobeNewswire
22:17
Oil-Dri Doubles its Historical Dividend Increase and Marks 21st Consecutive Year of Dividend Increas...
GlobeNewswire
22:16
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc...
GlobeNewswire
22:15
LogicMark, Inc. to Present at Virtual Emerging Growth Conference on June 12, 2024
GlobeNewswire
22:15
Project Energy Reimagined Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Q...
GlobeNewswire
22:15
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Confere...
GlobeNewswire
22:15
PetIQ, Inc. to Participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference
GlobeNewswire
22:10
EXAI STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in...
Newsfile Corp
22:10
ROSEN, A LEADING LAW FIRM, Encourages Northern Genesis Acquisition Corp. n/k/a The Lion Electric Com...
GlobeNewswire
22:10
NN, Inc. Executive Management to Present at the Sidoti June Small Cap Investor Conference
GlobeNewswire
22:09
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
GlobeNewswire
22:06
GDRX STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in...
GlobeNewswire
22:05
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Co...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page